Health Condition 1: C509- Malignant neoplasm of breast of unspecified site Health Condition 2: C509- Malignant neoplasm of breast of unspecified site
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients undergoing modified radical mastectomy Patients giving written consent ASA 1, 2 and 3
Exclusion criteria
Exclusion criteria: Patients operated for benign breast disease Patients undergoing repeat surgery or reconstructive breast surgery Allergic to Diclofenac, Ketoprofen or Lignocaine or any other drug used in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the numerical rating score (NRS) score between diclofenac, ketoprofen and lidocaine patch groups and to evaluate the post operative 24 hour intravenous fentanyl consumption through Patient controlled analgesia pumpTimepoint: 1 hour pre induction to 24 hour post operative | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate and document the complications and side effects of diclofenac, ketoprofen and lidocaine patch for post operative analgesia for 24 hours.Timepoint: 1 hour pre induction to 24 hour post operative | — |
Countries
India
Contacts
Swami Rama Himalayan University